Concomitant intake of tenofovir disoproxil fumarate (TDF) does not impair plasma exposure of ritonavir (RTV) boosted atazanavir (ATV) in HIV-1 infected adults.

被引：0
|
作者：
Hentig, NV
Haberl, A
Lutz, T
Klauke, S
Kurowski, M
Harder, S
Staszewski, S
机构：
[1] JW Goethe Univ Hosp, Inst Clin Pharmacol, Frankfurt, Germany
[2] Univ Frankfurt, HIV Treatment & Res Unit, Frankfurt, Germany
[3] Auguste Viktoria Krankenhaus, IFS Frankfurt Therapia GMBH, Frankfurt, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.11.072
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P18 / P18
页数：1
相关论文
共 41 条
  • [1] Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults
    Nils von Hentig
    Brenda Dauer
    Annette Haberl
    Stefan Klauke
    Thomas Lutz
    Schlomo Staszewski
    Sebastian Harder
    [J]. European Journal of Clinical Pharmacology, 2007, 63
  • [2] Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults
    von Hentig, Nils
    Dauer, Brenda
    Haberl, Annette
    Klauke, Stefan
    Lutz, Thomas
    Staszewski, Schlomo
    Harder, Sebastian
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (10) : 935 - 940
  • [3] Superior efficacy of dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) fixed dose combination (FDC) compared with ritonavir (RTV) boosted atazanavir (ATV) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in treatmentnai naive women with HIV-1 infection (ARIA Study)
    Orrell, C.
    Hagins, D.
    Belonosova, E.
    Porteiro, N.
    Walmsley, S.
    Falco, V.
    Man, C.
    Aylott, A.
    Buchanan, A.
    Wynne, B.
    Vavro, C.
    Aboud, M.
    Smith, K.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [4] A review of renal histology in HIV-1 infected individuals on tenofovir disoproxil fumarate (TDF), could there be glomerular involvement?
    Cevik, M.
    Leen, C.
    Raha, D.
    [J]. HIV MEDICINE, 2017, 18 : 31 - 31
  • [5] Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study
    Blanco, Jose L.
    Rojas, Jhon
    de Lazzari, Elisa
    Inciarte, Alexy
    Subirana, Mar
    Callau, Pilar
    Martinez-Rebollar, Maria
    Laguno, Montserrat
    Mallolas, Josep
    de la Mora, Lorena
    Torres, Berta
    Gonzalez-Cordon, Ana
    Martinez, Esteban
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (07) : 1974 - 1979
  • [6] Pharmacotherapy of HIV: A Focus on Atazanavir/Ritonavir a Potent and Convenient Once Daily Ritonavir Boosted Protease-Inhibitor for HIV-1 Infected Adults
    Allavena, Clotilde
    Trancart, Stephanie
    Cuzin, Lise
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 243 - 252
  • [7] Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial
    Soriano, Vicente
    Arasteh, Keikawus
    Migrone, Horacio
    Lutz, Thomas
    Opravil, Milos
    Andrade-Villanueva, Jaime
    Antunes, Francisco
    Di Perri, Giovanni
    Podzamczer, Daniel
    Taylor, Steve
    Domingo, Pere
    Gellermann, Holger
    de Rossi, Lothar
    [J]. ANTIVIRAL THERAPY, 2011, 16 (03) : 339 - 348
  • [8] In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers
    Vigano, Alessandra
    Mora, Stefano
    Giacomet, Vania
    Stucchi, Sara
    Manfredini, Valeria
    Gabiano, Clara
    Salvini, Filippo
    Cellini, Monica
    Tamburrini, Enrica
    Puzzovio, Maria
    Zuccotti, Gian Vincenzo
    [J]. ANTIVIRAL THERAPY, 2011, 16 (08) : 1259 - 1266
  • [9] Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors
    Liegeon, Geoffroy
    Harrison, Linda
    Nechba, Anouar
    Halue, Guttiga
    Banchongkit, Sukit
    Nilmanat, Ampaipith
    Yutthakasemsunt, Naruepon
    Pathipvanich, Panita
    Thongpaen, Suchart
    Lertkoonalak, Rittha
    Althaus, Thomas
    Lallemant, Marc
    Mary, Jean-Yves
    Jourdain, Gonzague
    [J]. JOURNAL OF INFECTION, 2019, 79 (05) : 454 - 461
  • [10] Efficacy of dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) fixed-dose combination (FDC) compared with ritonavir-boosted atazanavir (ATV/r) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in treatment-naive women with HIV-1 infection (ARIA study): subgroup analyses
    Johnson, Margaret
    Gatey, Caroline
    Manosuthi, Weeraweet
    Lazzarin, Adriano
    Podzamczer, Daniel
    Man, Choy
    Aylott, Alicia
    Buchanan, Annie
    Wynne, Brian
    Vavro, Cindy
    Aboud, Michael
    Smith, Kim
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
12345